ARROWHEAD PHARMACEUTICALS, INC. Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Arrowhead Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -200 %, a 273% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2024 was -200 %, a 273% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2023 was -53.6 %, a 30.8% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2022 was -41 %, a 27.1% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -200 -146 -273% Oct 1, 2023 Sep 30, 2024
2023 -53.6 -12.6 -30.8% Oct 1, 2022 Sep 30, 2023
2022 -41 -8.74 -27.1% Oct 1, 2021 Sep 30, 2022
2021 -32.3 -14.9 -85.9% Oct 1, 2020 Sep 30, 2021
2020 -17.4 -49.7 -154% Oct 1, 2019 Sep 30, 2020
2019 32.3 +89.5 Oct 1, 2018 Sep 30, 2019
2018 -57.2 -19.1 -50.1% Oct 1, 2017 Sep 30, 2018
2017 -38.1 +63.8 +62.6% Oct 1, 2016 Sep 30, 2017
2016 -102 -32.6 -46.9% Oct 1, 2015 Sep 30, 2016
2015 -69.4 -31.7 -84% Oct 1, 2014 Sep 30, 2015
2014 -37.7 +139 +78.7% Oct 1, 2013 Sep 30, 2014
2013 -177 +12.7 +6.67% Oct 1, 2012 Sep 30, 2013
2012 -190 Oct 1, 2011 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.